Zsuzsa Pápai

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

Stefan Sleijfer, Isabelle Ray‐Coquard, Zsuzsa Pápai et al. · Journal of Clinical Oncology · 2009 · 681 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

Paul Lorigan, Jaap Verweij, Zsuzsa Pápai et al. · Journal of Clinical Oncology · 2007 · 256 citations · Full text

Medicine, Oncology, Pharmacology +15

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

Charlotte Benson, Isabelle Ray‐Coquard, Stefan Sleijfer et al. · Gynecologic Oncology · 2016 · 67 citations

Medicine, Oncology, Surgery +12

Diagnosis of soft tissue tumors by fine‐needle aspiration with combined cytopathology and ancillary techniques

Zoltàn Sápi, Imre Antal, Zsuzsa Pápai et al. · Diagnostic Cytopathology · 2002 · 56 citations

Medicine, Oncology, Pathology +17

Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials

Florence Duffaud, Stefan Sleijfer, Saskia Litière et al. · European Journal of Cancer · 2015 · 43 citations

Medicine, Oncology, Pharmacology +13